| Industrial Conglomerates Industry | Industrials Sector | Rocky DiBenedetto CEO | OTC PINK Exchange | 268554201 CUSIP |
| CA Country | 8 Employees | - Last Dividend | 25 Jun 2009 Last Split | - IPO Date |
EKO International Corp, operating from Burlington, Canada, is notably recognized for its innovative approach in the healthcare sector, particularly in the treatment of peripheral neuropathy. The company harnesses its joint venture with NeuroVasc Clinical Inc., focusing on promoting and distributing advanced medical equipment based on frequency rhythmic electrical modulation systems (FREMS™). This collaboration not only marks a significant advancement in neuropathy treatment technologies but also extends its expertise to the operational management and establishment of clinics dedicated to treating patients with this cutting-edge equipment.
This state-of-the-art equipment is at the forefront of EKO International Corp's product offerings. Specifically designed for the treatment of peripheral neuropathy, FREMS™ technology utilizes rhythmic electrical modulation to manage and alleviate symptoms associated with this condition. It stands as a testament to the company’s commitment to leveraging advanced technologies for improving patient outcomes in Canada.
In partnership with NeuroVasc Clinical Inc., EKO International extends its services beyond equipment distribution to include the establishment and management of clinics. These specialized clinics are dedicated to treating patients with peripheral neuropathy using FREMS™ technology. This comprehensive approach not only ensures the availability of cutting-edge treatment options but also promotes a standardized quality of care for patients suffering from neuropathy.